Instituto de Diagnostico SA
SGO:INDISA
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1 199.3
1 550
|
Price Target |
|
We'll email you a reminder when the closing price reaches CLP.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one INDISA stock under the Base Case scenario is 1 604.74 CLP. Compared to the current market price of 1 526.8 CLP, Instituto de Diagnostico SA is Undervalued by 5%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Instituto de Diagnostico SA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for INDISA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Instituto de Diagnostico SA
Balance Sheet Decomposition
Instituto de Diagnostico SA
Current Assets | 96.8B |
Cash & Short-Term Investments | 16.6B |
Receivables | 75.9B |
Other Current Assets | 4.2B |
Non-Current Assets | 175.4B |
Long-Term Investments | 7.8B |
PP&E | 150.5B |
Intangibles | 9B |
Other Non-Current Assets | 8.1B |
Current Liabilities | 81.2B |
Accounts Payable | 23.8B |
Accrued Liabilities | 1.5B |
Other Current Liabilities | 55.9B |
Non-Current Liabilities | 84.6B |
Long-Term Debt | 83.7B |
Other Non-Current Liabilities | 892.8m |
Earnings Waterfall
Instituto de Diagnostico SA
Revenue
|
230.6B
CLP
|
Cost of Revenue
|
-176.6B
CLP
|
Gross Profit
|
54B
CLP
|
Operating Expenses
|
-42.4B
CLP
|
Operating Income
|
11.6B
CLP
|
Other Expenses
|
-6.2B
CLP
|
Net Income
|
5.4B
CLP
|
Free Cash Flow Analysis
Instituto de Diagnostico SA
CLP | |
Free Cash Flow | CLP |
INDISA Profitability Score
Profitability Due Diligence
Instituto de Diagnostico SA's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Score
Instituto de Diagnostico SA's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
INDISA Solvency Score
Solvency Due Diligence
Instituto de Diagnostico SA's solvency score is 47/100. The higher the solvency score, the more solvent the company is.
Score
Instituto de Diagnostico SA's solvency score is 47/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
INDISA Price Targets Summary
Instituto de Diagnostico SA
According to Wall Street analysts, the average 1-year price target for INDISA is 1 938 CLP with a low forecast of 1 919 CLP and a high forecast of 1 995 CLP.
Dividends
Current shareholder yield for INDISA is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Instituto de Diagnostico SA provides medical health care and insurance services. The firm manages and operates Clinica Indisa, a private clinic located in the Santiago Metropolitan Region, which provides such hospital and outpatient services, as internal medicine admission and surgery, intensive and intermediate care units, pediatrics and neonatology, post-surgery recuperation, clinical laboratories, blood donation, radiology, endocrinology, computerized tomography, magnetic resonance imaging (MRI), nuclear medicine, hemodialysis and other outpatient procedures and services that cover all areas of medicine. As of December 31, 2011, the Company owned such subsidiaries as Servicios Integrados de Salud Ltda, Servicios Complementarios de Salud Ltda, Inmobiliaria San Cristobal SA and Indisa Laboratorio Ltda.
Officers
The intrinsic value of one INDISA stock under the Base Case scenario is 1 604.74 CLP.
Compared to the current market price of 1 526.8 CLP, Instituto de Diagnostico SA is Undervalued by 5%.